Ro at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Ro brings 6 presentations to ObesityWeek 2026 in National Harbor. Its research draws on telehealth patients taking GLP-1 drugs, including oral semaglutide, tracking weight loss, early side effects and gaps in insurance coverage. It also looks at how common cancer is among patients seeking weight care through telehealth.

OrganizationObesityWeek 2026 Attendance
Ro
New York, NY
Digital health
Direct-to-patient telehealth company offering online treatment, including weight-management care with GLP-1 medications.
Poster
Sun Nov 15
2:30pm–3:30pm
Poster
Sun Nov 15
2:30pm–3:30pm

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Ro

Tell us what you sell and we’ll find the people at Ro most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction